Evidence map›Paper›PMID 34231395›Full record

ArticleJournal of primary care & community health

PROMIS Scales for Assessment of Persistent Post-COVID Symptoms: A Cross Sectional Study.

Ravindra Ganesh, Aditya K Ghosh, Mark A Nyman, Ivana T Croghan, Stephanie L Grach, Christopher V Anstine, Bradley R Salonen, Ryan T Hurt

Registry-linked trialAbstract read
In one paragraph

Article in Journal of primary care & community health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05638620 (Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2), which is not on this map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05638620 phase1completednot on this map

Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)

TypeinterventionalSponsorJonathann Kuo, MDRan2023 to 2023Enrolled20ConditionsPost Acute COVID-19 Syndrome, Long COVID, Long Covid19, COVID-19 RecurrentArmsstellate ganglion block with 0.5% bupivacaine
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Post-COVID-19 fatigue: A systematic review.Frontiers in psychiatry · 2022
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Embedding research study recruitment within the patient portal preCheck-in.Journal of the American Medical Informatics Association : JAMIA · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ravindra GaneshMayo Clinic, Rochester, MN, USA.ORCID 0000-0002-6877-1712
Aditya K GhoshMayo Clinic, Rochester, MN, USA.
Mark A NymanMayo Clinic, Rochester, MN, USA.
Ivana T CroghanMayo Clinic, Rochester, MN, USA.ORCID 0000-0003-3464-3525
Stephanie L GrachMayo Clinic, Rochester, MN, USA.ORCID 0000-0002-8337-6219
Christopher V AnstineMayo Clinic, Rochester, MN, USA.
Bradley R SalonenMayo Clinic, Rochester, MN, USA.
Ryan T HurtMayo Clinic, Rochester, MN, USA.

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
NCATS NIH HHS UL1 TR000135
6 · The paper itself

Abstract

objectivePersistent post-COVID symptoms are estimated to occur in up to 10% of patients who have had COVID-19. These lingering symptoms may persist for weeks to months after resolution of the acute illness. This study aimed to add insight into our understanding of certain post-acute conditions and clinical findings. The primary purpose was to determine the persistent post COVID impairments prevalence and characteristics by collecting post COVID illness data utilizing Patient-Reported Outcomes Measurement Information System (PROMIS

methodsA cross-sectional study and 6-months Mayo Clinic COVID recovered registry data were used to evaluate continuing symptoms severity among the 817 positive tested patients surveyed between March and September 2020. The resulting PROMIS

resultsThe large sample size (n = 817) represented post hospitalized and other managed outpatients. Persistent post COVID impairments prevalence and characteristics were determined to be demographically young (44 years), white (87%), and female (61%). Dysfunction as measured by the PROMIS

conclusionPatient response on the PROMIS

Indexed as

COVID-19Cross-Sectional StudiesFatigueFemaleHealth StatusHumansQuality of LifeSARS-CoV-2Surveys and QuestionnairesCOVID-19fatiguelong haulersPASCpost COVID symptomspost COVID syndromePROMISSARS-CoV-2social rolessurvey

Identifiers

PMID34231395
PMCPMC8267017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.